Explore Revance through 6 example sentences from English. Ideal for language learners, writers and word enthusiasts.
Revance in a sentence
Using Revance
- In the example corpus, revance often appears in combinations such as: revance therapeutics, of revance.
Context around Revance
- Average sentence length in these examples: 21.5 words
- Position in the sentence: 5 start, 1 middle, 0 end
- Sentence types: 6 statements, 0 questions, 0 exclamations
Corpus analysis for Revance
- In this selection, "revance" usually appears near the start of the sentence. The average example has 21.5 words, and this corpus slice is mostly made up of statements.
- Around the word, therapeutics stand out and add context to how "revance" is used.
- Recognizable usage signals include revance therapeutics inc and revance therapeutics posted. That gives this page its own corpus information beyond isolated example sentences.
- By corpus frequency, "revance" sits close to words such as aaba, aafc and aaib, which helps place it inside the broader word index.
Example types with revance
The same corpus examples are grouped by length and sentence type, making it easier to see the contexts in which the word appears:
See if Revance Therapeutics can continue to show renewed price strength and hit that benchmark. (15 words)
ProShare Advisors LLC boosted its holdings in shares of Revance Therapeutics by 3.8% in the third quarter. (18 words)
Revance Therapeutics, Inc. has a 1 year low of $2.30 and a 1 year high of $9.74. (19 words)
Guggenheim raised shares of Revance Therapeutics from a neutral rating to a buy rating and set a $41.00 price objective on the stock in a research report on Friday, November 16th. (32 words)
Revance Therapeutics posted sales of $2.36 million in the same quarter last year, which suggests a negative year-over-year growth rate of 83.1%. (26 words)
Revance Therapeutics, Inc. has a 1 year low of $2.30 and a 1 year high of $9.74. (19 words)
Example sentences (6)
ProShare Advisors LLC boosted its holdings in shares of Revance Therapeutics by 3.8% in the third quarter.
Revance Therapeutics, Inc. has a 1 year low of $2.30 and a 1 year high of $9.74.
Revance Therapeutics Inc has a one year low of $9.88 and a one year high of $27.97.
Guggenheim raised shares of Revance Therapeutics from a neutral rating to a buy rating and set a $41.00 price objective on the stock in a research report on Friday, November 16th.
Revance Therapeutics posted sales of $2.36 million in the same quarter last year, which suggests a negative year-over-year growth rate of 83.1%.
See if Revance Therapeutics can continue to show renewed price strength and hit that benchmark.
Common combinations with revance
These word pairs occur most frequently in English texts:
- revance therapeutics 7×
- of revance 2×